Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study
نویسندگان
چکیده
منابع مشابه
The Prevalence of Limited Joint Mobility in Patients with Type I Diabetes Mellitus in Kerman
Background & Aims: Limited joint mobility (LJM) is a complication of diabetes mellitus, which usually begins from the small joints of hands and is associated with long-term complications of diabetes, such as retinopathy and nephropathy. The aim of this study was to find the prevalence of Limited Joint Mobility in patients with type 1 diabetes mellitus in Kerman in 2003. Methods: Sixty-six patie...
متن کاملReduced prevalence of limited joint mobility in type 1 diabetes in a U.K. clinic population over a 20-year period.
OBJECTIVE Limited joint mobility (LJM), one of the earliest clinically apparent long-term complications of type 1 diabetes, is a risk marker for subsequent microvascular complications. We hypothesize that the prevalence of LJM may have decreased during the past two decades due to improved standards of glycemic control. RESEARCH DESIGN AND METHODS A single observer performed a survey in 204 co...
متن کاملLimited joint mobility in Type I diabetes mellitus.
Forty-two of 115 patients with Type I (insulin dependent) diabetes were found to have limited joint mobility affecting mainly the small joints of the hands. The presence of joint abnormalities was related to duration of diabetes. Patients with limited joint mobility had a significantly higher incidence of proliferative retinopathy than patients with normal joint mobility and a similar duration ...
متن کاملBacterial infections in patients with type 1 diabetes: a 14-year follow-up study
OBJECTIVE This study explored the annual occurrence/incidence of bacterial infections, and their association with chronic hyperglycemia and diabetic nephropathy, in patients with type 1 diabetes. DESIGN In a register-based follow-up study, we investigated the frequency of bacterial infections in patients with type 1 diabetes (n=4748) and age-matched and sex-matched non-diabetic control (NDC) ...
متن کاملSoluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
BACKGROUND Advanced glycation end products (AGEs) play a role in the development of late complications and atherosclerosis in diabetes by engaging the receptor for advanced glycation end products, RAGE. Receptor binding leads to activation of the vascular endothelium and increased inflammation in the vessel wall. The soluble variants of the receptor, endogenous secretory RAGE (esRAGE) and the c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Endocrinology
سال: 2018
ISSN: 1687-8337,1687-8345
DOI: 10.1155/2018/1897058